Literature DB >> 24767193

Behçet's disease as a systemic disease.

M Cem Mat1, Ayşegül Sevim1, Izzet Fresko2, Yalçın Tüzün3.   

Abstract

Behçet's disease usually begins with cutaneous manifestations, such as recurrent aphthous stomatitis, genital ulcers, erythema nodosum-like lesions, papulopustular findings, and pathergy phenomenon. Recurrent aphthous stomatitis is generally the first sign, and other findings may develop in the course of the disease. There is no specific diagnostic available for Behçet's disease. It is most prevalent among patients along the ancient Silk Road. The high frequency of HLA-B51 among a wide range of ethnic populations favors the role of genetic factors. Behçet's disease usually appears in the third to fourth decade of life, and is rarely seen in children and adults over 50 years of age. It affects both genders equally, but the course of the disease is more severe in men. Eye involvement leading to loss of vision, plus vascular, articular, and central nervous system involvement are more commonly observed among men. Behçet's disease is a systemic inflammatory disorder. A complex genetic background, coupled with innate and adaptive immune system activation, causes the diverse clinical manifestations that characterize the clinical picture.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24767193     DOI: 10.1016/j.clindermatol.2013.11.012

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  13 in total

1.  Behçet's syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics.

Authors:  Jurgen Sota; Donato Rigante; Giacomo Emmi; Giuseppe Lopalco; Ida Orlando; Gian Marco Tosi; Bruno Frediani; Antonio Vitale; Silvana Guerriero; Florenzo Iannone; Lorenzo Vannozzi; Claudia Fabiani; Luca Cantarini
Journal:  Intern Emerg Med       Date:  2020-02-01       Impact factor: 3.397

2.  Identification of physical and psychosocial problems based on symptoms in patients with Behçet's disease.

Authors:  Hideyo Tsutsui; Hirotoshi Kikuchi; Hiroko Oguchi; Kyoko Nomura; Takayoshi Ohkubo
Journal:  Rheumatol Int       Date:  2019-12-04       Impact factor: 2.631

Review 3.  Epigenetics and Vasculitis: a Comprehensive Review.

Authors:  Paul Renauer; Patrick Coit; Amr H Sawalha
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

4.  Ultrasonographic assessment of femoral cartilage thickness in patients with and without uveitis in Behçet's disease.

Authors:  Emre Ata; Murat Kosem; Tugba Ozsoy-Unubol
Journal:  Rheumatol Int       Date:  2019-07-23       Impact factor: 2.631

5.  Association between MEFV Mutations M694V and M680I and Behçet's Disease: A Meta-Analysis.

Authors:  Ziyan Wu; Shulan Zhang; Jing Li; Si Chen; Ping Li; Fei Sun; Xiaoting Wen; Wenjie Zheng; Fengchun Zhang; Yongzhe Li
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

6.  Behçet's: A Disease or a Syndrome? Answer from an Expression Profiling Study.

Authors:  Ali Kemal Oğuz; Seda Taşır Yılmaz; Çağdaş Şahap Oygür; Tuba Çandar; Irmak Sayın; Sibel Serin Kılıçoğlu; İhsan Ergün; Aşkın Ateş; Hilal Özdağ; Nejat Akar
Journal:  PLoS One       Date:  2016-02-18       Impact factor: 3.240

7.  Increased Serum Antibody Titer against HPV-16 Antigen in Patients with Behçet's Disease.

Authors:  Kyu Yeun Kim; Do Young Kim; Jimyung Seo; Yuri Ahn; Dong Soo Kim
Journal:  J Korean Med Sci       Date:  2017-04       Impact factor: 2.153

8.  Gene Expression Profiling in Behcet's Disease Indicates an Autoimmune Component in the Pathogenesis of the Disease and Opens New Avenues for Targeted Therapy.

Authors:  Antonio Puccetti; Piera Filomena Fiore; Andrea Pelosi; Elisa Tinazzi; Giuseppe Patuzzo; Giuseppe Argentino; Francesca Moretta; Claudio Lunardi; Marzia Dolcino
Journal:  J Immunol Res       Date:  2018-04-24       Impact factor: 4.818

9.  MicroRNA Expression Profiling in Behçet's Disease.

Authors:  Antonio Puccetti; Andrea Pelosi; Piera Filomena Fiore; Giuseppe Patuzzo; Claudio Lunardi; Marzia Dolcino
Journal:  J Immunol Res       Date:  2018-05-07       Impact factor: 4.818

10.  Endocan Measurement for Active Behçet Disease.

Authors:  Ayhan Kul; Orhan Ateş; Meltem Alkan Melikoğlu; Mahir Uğur; Nurinnisa Öztürk; Gülsüm Erkayhan; İbrahim Koçer
Journal:  Arch Rheumatol       Date:  2017-03-24       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.